[1] Mishra R,Rohatgi I. .2021 .. Indian Journal of Critical Care Medicine, 25(S2) : S166-70.
[2] Van Griensven J,Diro E. Visceral,Leishmaniasis E. Visceral .2019 .. Infectious Disease Clinics of North America, 33(1) : 79-99.
[3] Abadías-Granado I,Diago A,Cerro PA,Palma-Ruiz AM,Gilaberte Y. .2021 .Leishmaniasis cutánea y mucocutánea. Actas Dermosifiliog, 112(7) : 601-18.
[4] Mann S,Frasca K,Scherrer S,Henao-Martínez AF,Newman S,Ramanan P .2021 .A Review of Leishmaniasis: Current Knowledge and Future Directions. Current Tropical Medicine Reports, 8(2) : 121-32.
[5] Omondi ZN,Arserim SK,Töz S,Özbel Y.,Host-Parasite Interactions .2022 .Regulation of Leishmania Infection in Sand Fly. Acta Parasitologica, 67(2) : 606-18.
[6] Maksoud S,Ortega JT,Hidalgo M,Rangel HR .2022 .Leishmania donovani and HIV co-infection in vitro: Identification and characterization of main molecular players. Acta Tropica, 228 : 106248.
[7] Word Health .2020 .Organization. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021-2030. Word Heal Organ, : 196.
[8] Novais Scott P,FO Scott P .2016 .Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nature Reviews Immunology, 16(9) : 581-92.
[9] Dorlo TPC,van Thiel PPAM,Huitema ADR,Keizer RJ,de Vries HJC,Beijnen JH .2008 .. Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients. Antimicrobial Agents and Chemotherapy, 52(8) : 2855-60.
[10] Monge-Maillo B,Lopez-Velez R .2015 .Miltefosine for Visceral and Cutaneous Leishmaniasis: Drug Characteristics and Evidence-Based Treatment Recommendations. Clinical Infectious Diseases, 60(9) : 1398-404.
[11] Ajijur R,Salman A,Ahmad KMK .2021 .Combinatorial Design to Decipher Novel Lead Molecule against Mycobacterium tuberculosis. Biointerface Research in Applied Chemistry, 11(5) : 12993-3004.
[12] Khan MKA,Pokharkar NB,Al-Khodairy FM,Al-Marshad FM,Arif JM .2020 .Structural Perspective on Molecular Interaction of IgG and IgA with Spike and Envelope Proteins of SARS-CoV-2 and Its Implications to NonSpecific Immunity. , 11(3) : 10923-39.
[13] .2022 .Target‐based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesinlike protein KIFC1. Cell Biochemistry & Function, 40(5) : 451-472.
[14] Bioinformatics .2011 .. , 27(3) : 343-50.
[15] AS. Lead Alwabli .2022 .Identification against 3C-like Protease of SARS-CoV-2 Via Target-based Virtual Screening and Molecular Dynamics Simulation. Journal of Young Pharmacists, 14(2) : 179-86.
[16] Subramanya HS,Bird LE,Brannigan JA,Wigley DB .1996 .Crystal structure of a DExx box DNA helicase. Nature, 384(6607) : 379-83.
[17] Bioinformatics .2020 .. , 36(6) : 1765-71.
[18] Brooks BR,Bruccoleri RE,Olafson BD,States DJ,Swaminathan S,Karplus M. .1983 .CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry, 4(2) : 187-217.
[19] .2020 .Computational Exploration of Dibenzo [a,l] Pyrene Interaction to DNA and its Bases: Possible Implications to Human Health. , 11(4) : 11272-83.
[20] Kiss R,Sandor M,Szalai FA M .2012 .A public web service for drug discovery. Journal of Cheminformatics, 4(S1) : P17.
[21] Shakil S. .2019 .Molecular interaction of investigational ligands with human brain acetylcholinesterase. Journal of Cellular Biochemistry, 120(7) : 11820-30.
[22] Ware JM,O'Connell EM,Brown T,Wetzler L,Talaat KR,Nutman TB .2021 .Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis. Clinical Infectious Diseases, 73(7) : e2457-562.
[23] Castro M del M ,Gomez MA,Kip AE,Cossio A,Ortiz E,Navas A .2017 .Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis. Antimicrobial Agents and Chemotherapy, 61(3) : e02198-16.
[24] Brooks BR,Brooks CL,Mackerell AD,Nilsson L,Petrella RJ,Roux B .2009 .CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30(10) : 1545-614.
[25] .2010 .. Journal of Computational Chemistry, 31(16) : 2967-70.
[26] Khan MKA,Akhtar S,Arif JM .2018 .Development of In Silico Protocols to Predict Structural Insights into the Metabolic Activation Pathways of Xenobiotics. Interdisciplinary Sciences: Computational Life Sciences, 10(2) : 329-45.
[27] Khan MKA,Akhtar S,Arif JM .2018 .Structural Insight into the Mechanism of Dibenzo[a,l]pyrene and Benzo[a]pyreneMediated Cell Proliferation Using Molecular Docking Simulations. Interdisciplinary Sciences: Computational Life Sciences, 10(4) : 653-73.
[28] Daina A,Michielin O,Zoete V. .2017 .SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1) : 42717.
[29] .2019 .. International Journal of Environmental Research and Public Health, 16(6) : 923.
[30] Egan WJ,Baldwin JJ KM .2000 .Prediction of Drug Absorption Using Multivariate Statistics. Journal of Medicinal Chemistry, 43(21) : 3867-77.
[31] Drug Delivery Reviews Advanced .2002 .. , 54(3) : 273-89.
[32] Baell JB,Holloway GA .2010 .New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays. Journal of Medicinal Chemistry, 53(7) : 2719-40.
[33] ChemMedChem .2008 .. , 3(3) : 435-44.
[34] Van Der Spoel D,Lindahl E,Hess B,Groenhof G,Mark AE,Berendsen HJC .2005 .GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16) : 1701-18.
[35] Vanommeslaeghe K,MacKerell AD K .2012 .Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing. Journal of Chemical Information and Modeling, 52(12) : 3144-54.
[36] Vanommeslaeghe K,Hatcher E,Acharya C,Kundu S,Zhong S,Shim J .2010 .CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM allatom additive biological force fields. Journal of Computational Chemistry, 31(4) : 671-90.
[37] HG Petersen .1995 .Accuracy and efficiency of the particle mesh Ewald method. Journal of Chemical Physics, 103(9) : 3668-79.
[38] Stenberg S,Stenqvist B. .2020 .An Exact Ewald Summation Method in Theory and Practice. Journal of Physical Chemistry, 124(19) : 3943-6.
[39] Fischer NM ,van Maaren PJ,Ditz JC,Yildirim A .2015 .Properties of Organic Liquids when Simulated with Long-Range Lennard-Jones Interactions. Journal of Chemical Theory and Computation, 11(7) : 2938-44.
[40] .1993 .PROCHECK: a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2) : 283-91.
[41] .2021 .. Journal of Molecular Structure, 1236(1) : 130337.
[42] Ghose AK,Viswanadhan VN,Wendoloski JJ . .A KnowledgeBased Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases. , : .
[43] .1999 .. Journal of Combinatorial Chemistry, 1(1) : 55-68.
[44] Veber DF,Johnson SR,Cheng H,Smith BR,Ward KW,Kopple KD .2002 .Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. Journal of Medicinal Chemistry, 45(12) : 2615-23.
[45] Muegge I,Heald SL,Brittelli D .2001 .Simple Selection Criteria for Drug-like Chemical Matter. Journal of Medicinal Chemistry, 44(12) : 1841-6.
[46] Martin YC. A Bioavailability,Score YC. A Bioavailability .2005 .. , 48(9) : 3164-70.
[47] Kausar MA,Shahid S,Anwar S,Kuddus M,Khan MKA,Alotaibi AD,Docking and MD Simulation Molecular .2022 .Study. Indian Journal of Pharmaceutical Education and Research, 56(1s) : s21-31.
[48] Kausar MA,Shahid S,Anwar S,Kuddus M,Khan MKA,Khalifa AM .2022 .Identifying the alpha-glucosidase inhibitory potential of dietary phytochemicals against diabetes mellitus type 2 via molecular interactions and dynamics simulation. Cellular and Molecular Biology, 67(5) : 16-26.
[49] Gupta R,Brosh RMJ .2008 .Anti-Cancer Agents in Medicinal Chemistry. , 8(4) : 390-401.
[50] Singleton MR,Dillingham MS,Gaudier M,Kowalczykowski SC,Wigley DB .2004 .Crystal Structure of RecBCD Enzyme Reveals a Machine for Processing DNA Breaks. Nature, 432(7014) : 187-193.
[51] Itsathitphaisarn O,Wing RA,Eliason WK,Wang J,Steitz TA .2012 .The Hexameric Helicase DnaB Adopts a Nonplanar Conformation during Translocation. Cell, 151(2) : 267-277.
[52] Imanishi H,Sasaki YF,Matsumoto K,Watanabe M,Ohta T,Shirasu Y,Tutikawa K. .1990 .Suppression of 6-TG-resistant mutations in V79 cells and recessive spot formations in mice by vanillin. Mutation Research, 243(2) : 151-8.
[53] Das S,Roy P,Mondal S,Bera T,Mukherjee A .2013 .One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis. Colloids Surf B Biointerfaces, : 27-34.
[54] Singh PP,Chakraborty P. Malaria PP .2016 .: autophagy as a potential therapeutic target. Journal of Pharmacy and Pharmacology, 4 : 298-306.